Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Total Assets of $14.89 million for the year ending 2024.
- CHINA PHARMA HOLDINGS, INC. showed a decrease of -9.6% in Total Assets from 2023 to 2024.
- This data is from CHINA PHARMA HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $149.12 million | Q1 2012: $163.62 million | Q2 2012: $164.89 million | Q3 2012: $166.05 million | Q1 2013: $159.26 million | Q2 2013: $158.93 million | Q3 2013: $162.49 million | Q1 2014: $154.34 million | Q2 2014: $146.03 million | Q3 2014: $140.53 million | Q1 2015: $125.16 million | Q2 2015: $121.24 million | Q3 2015: $112.68 million | Q1 2016: $97.03 million | Q2 2016: $91.98 million | Q3 2016: $87.41 million | Q1 2017: $78.14 million | Q2 2017: $77.12 million | Q3 2017: $74.99 million | Q1 2018: $62.13 million | Q2 2018: $58.31 million | Q3 2018: $52.53 million | Q1 2019: $45.24 million | Q2 2019: $43.03 million | Q3 2019: $39.90 million | Q1 2020: $22.44 million | Q2 2020: $23.17 million | Q3 2020: $21.12 million | Q1 2021: $19.85 million | Q2 2021: $19.94 million | Q3 2021: $18.18 million | Q1 2022: $21.04 million | Q2 2022: $17.92 million | Q3 2022: $16.20 million | Q1 2023: $17.36 million | Q2 2023: $15.70 million | Q3 2023: $15.35 million | Q1 2024: $16.19 million | Q2 2024: $14.26 million | Q3 2024: $13.47 million | Q4 2024: $14.89 million | Q1 2025: $14.22 million | Q2 2025: $13.77 million | Q3 2025: $15.80 million.
- Over the full 15 years of available data (2010 to 2024), CHINA PHARMA HOLDINGS, INC.'s Total Assets has declined by 88.7%.
- Historical annual values: Fiscal year 2024: $14.89 million | Fiscal year 2023: $16.47 million | Fiscal year 2022: $17.78 million | Fiscal year 2021: $22.65 million | Fiscal year 2020: $21.12 million | Fiscal year 2019: $22.24 million | Fiscal year 2018: $45.38 million | Fiscal year 2017: $59.95 million | Fiscal year 2016: $78.52 million | Fiscal year 2015: $96.51 million | Fiscal year 2014: $121.08 million | Fiscal year 2013: $157.61 million | Fiscal year 2012: $163.24 million | Fiscal year 2011: $156.39 million | Fiscal year 2010: $131.75 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: